EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study

David Bergman iD, Fahim Ebrahimi, Jiangwei Sun, Cecilia Norin, Kaziwe Mollazadegan, Jonas F Ludvigsson

United European Gastroenterology Journal · 2024

DOI: 10.1002/ueg2.12623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von David Bergman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Colitis, Microscopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Karolinska Institutet, Stockholms Läns Landsting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microscopic colitis (MC) is an inflammatory disorder of the colon. To date, the relationship between inflammatory eye diseases and MC is unclear.

Objective

To assess whether inflammatory eye disease (iridocyclitis and episcleritis) is a risk factor for MC.

Methods

We conducted a nationwide matched case control study in Sweden leveraging the ESPRESSO‐study (a Swedish database containing data on all biopsies from the gastrointestinal tract from 1965 to 2017). In total, we identified 14,338 patients with biopsy‐verified MC (diagnosed from 1981 to 2017). Patients with MC were matched (by age, sex, county and year of birth) with 68,753 controls from the general population and the occurrence of preceding inflammatory eye diseases (defined as diagnosis of episcleritis or iridocyclitis) in the two groups was compared. Multivariable adjusted odds ratios (aORs) were calculated using conditional logistic regression conditioned on the matching variables.

Results

A majority of patients with MC were women (71.9%) and the median age at MC diagnosis was 63.3 years (interquartile range (IQR) = 50.7–72.6). Some 225 (1.6%) MC patients had an earlier record of inflammatory eye disease compared with 614 (0.9%) in controls. These figures corresponded to an aOR of 1.77 (95% CI = 1.52–2.07) for inflammatory eye diseases in patients with MC. Compared to siblings, the aOR for previous inflammatory eye diseases in MC was 1.52 (95% CI = 1.17–1.98) and patients treated with budesonide, as a proxy for clinically significant disease, had a somewhat higher aOR for previous inflammatory eye diseases.

Conclusion

Inflammatory eye diseases are more common in patients subsequently being diagnosed with MC. Our findings highlight that these conditions may have shared causes and inflammatory pathways and are of clinical interest to gastroenterologists, ophthalmologists and general practitioners.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, MicroscopicHumansFemaleMaleMiddle AgedCase-Control StudiesRisk FactorsAgedSwedenIridocyclitisScleritisBudesonide

Stichwörter der Autor:innen

budesonidecase‐control studyepidemiologyiridocyclitismicroscopic colitisnationwideuveitis

Substanzen

Budesonide

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Gastroenterology and Hepatology, University Digestive Health Care Center Basel-Clarunis, Basel, Switzerland.
  • Sankt Eriks Eye Hospital, Stockholm, Sweden.
  • Department of Ophthalmology, Västmanland Hospital, Västerås, Sweden.
  • Department of Pediatrics, Orebro University Hospital, Orebro, Sweden.
  • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA.

ORCID-Profile: David Bergman

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Karolinska Institutet
  • Stockholms Läns Landsting

Zitieren

APA

Bergman, D., Ebrahimi, F., Sun, J., Norin, C., Mollazadegan, K., & Ludvigsson, J. F. (2024). Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12623

Vancouver

Bergman D, Ebrahimi F, Sun J, Norin C, Mollazadegan K, Ludvigsson JF. Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12623

BibTeX
@article{Bergman2024,
  author = {Bergman, David and Ebrahimi, Fahim and Sun, Jiangwei and Norin, Cecilia and Mollazadegan, Kaziwe and Ludvigsson, Jonas F},
  title = {Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  doi = {10.1002/ueg2.12623}
}
Kostenlos starten →